Stephen F Traynelis

Title: **The Innovative Contributions of Stephen F Traynelis**

Introduction

Stephen F Traynelis, an accomplished inventor based in Decatur, GA, has made significant contributions to the field of neuroscience through his innovative work in developing novel pharmaceutical compounds. With a total of 11 patents to his name, Traynelis has focused his research on the modulation of NMDA receptors, which are critical in various neurological conditions.

Latest Patents

One of Traynelis's most recent patents includes the development of Thieno[2,3-d]pyrimidin-4-one derivatives as NMDAR modulators. This patent discloses these derivatives as modulators of NMDA receptors, detailing pharmaceutical compositions that incorporate these compounds or their pharmaceutically acceptable salts or prodrugs. The applications of these compositions are aimed at managing cognitive disorders, particularly focusing on prevention and treatment of neurological conditions linked to NMDA receptors.

Another notable patent from Traynelis is centered around GluN2C/D subunit selective antagonists of the N-methyl-D-aspartate receptor. This patent outlines a compound, along with its salts and prodrugs, designed for treating various neurological disorders. These disorders include offering neuroprotection, preventing neurodegeneration, and addressing conditions like neuropathic pain, schizophrenia, psychoses, or depression. Interestingly, his compounds can be utilized in conjunction with other active ingredients, broadening their therapeutic potential.

Career Highlights

Throughout his illustrious career, Stephen F Traynelis has been affiliated with prominent institutions, including Emory University and Neurop, Inc. His work within these organizations has provided him with a strong foundation to pursue his innovative research and contribute to advancements in the pharmaceutical field.

Collaborations

Traynelis has collaborated with notable individuals in his field, including Dennis C Liotta and Ethel Garnier. These collaborations have played a crucial role in his research endeavors and the successful development of his patented inventions.

Conclusion

Stephen F Traynelis's dedication to advancing neurological treatments through his patents reflects his commitment to science and innovation. His work continues to pave the way for potential breakthroughs in the management of cognitive and neurodegenerative disorders, underscoring the vital role of inventors in the healthcare field.